The sinus node inhibitor UL-FS 49 lacks significant inotropic effect

Journal of Cardiovascular Pharmacology

Volumn 19, Issue 2, 1992, Pages 264-271

  Chen, Zengyi ^a   Slinker, Bryan K ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Hemodynamics; Inotropic state; Multiple regression modeling; Ventricular function

Indexed keywords

ZATEBRADINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE REGRESSION; NONHUMAN; PRIORITY JOURNAL; SINUS NODE;

ALGORITHMS; ANIMAL; BENZAZEPINES; CARDIOVASCULAR AGENTS; COMPARATIVE STUDY; DOGS; FEMALE; HEMODYNAMICS; MALE; MYOCARDIAL CONTRACTION; STIMULATION, CHEMICAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VENTRICULAR FUNCTION, LEFT;

EID: 0026602324     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199202000-00015     Document Type: Article

References (30)

1. Doerr T, Trautwein W. On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS 49. Arch Pharmacol 1990;341:331-40.
2. Kobinger W, Lillie C. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4 dimethoxyphenyI)ethyl]methylimino] propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent." Eur J Pharmacol 1984;104:9-18.
3. Lillie C, Kobinger W. Investigations into the bradycardic effects of UL-FS 49 ( 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylimino] propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria. J Cardiovasc Pharmcol 1986;8:791-7.
4. Franke H, Su CAPF, Schumacher K, Seiberling M. Clinical pharmacology of two specific bradycardic agents. Eur Heart J 1987;8(suppl L):91-8.
5. Guth BD, Heusch G, Seitekberger R, Matsuzaki M, Ross J. Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia. Eur Heart J 1987;8:61-8.
6. Krumpl G, Schneider W, Raberger G. Can exercise-induced regional contractile dysfunction be prevented by selective bradycardic agents? Naunyn Schmiedebergs Arch Pharmacol 1986;334:540-3.
7. Riley DC, Gross GJ, Kampine JP, Warltier DC. Specific bradycardic agents, a new therapeutic modality for anesthesiology: Hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs. Anesthesiology 1987;67:707-16.
8. Dammgen JW, Lamping KA, Gross GJ. Action of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function. J Cardiovasc Pharmcol 1985;7:71-9.
9. Krumpl G, Winkler M, Schneider W, Raberger G. Comparison of the hemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs. Br J Pharmacol 1988;94:55-64.
10. Raberger G, Krumpl G, Schneider W1 Mayer N. Effects of specific bradycardic agents on exercise-induced regional myocardial dysfunction in dogs. Eur Heart J 1987;8:53-9.
11. Indolfi C, Guth BD, Miura T, Miyazaki S, Schulz R, Ross J Jr. Mechanisms of improved ischemic regional dysfunction by bradycardia, studies on UL-FS 49 in swine. Circulation 1989;80:983-93.
12. Raberger G, Krumpl G, Mayer N, Schneider W. Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs. Int J Cardiol1987; 14: 343-54.
13. Slinker BK. Cardiac cycle length modulates cardiovascular regulation that depends on previous beat contraction history. Circ Res 1991;69:2-11.
14. Slinker BK, Glantz SA. Beat-to-beat regulation of left ventricular function in the intact cardiovascular system. Am J Physiol 1989;256:R962-75.
15. Baan J, Van Der Veld ET, De Bruin HDG, et al. Continuous measurement of left ventricular volume in animal and humans by conductance catheter. Circulation 1984;70:812-23.
16. Abel FR. Maximal negative dp/dt as an indicator of end of systole. Am J Physiol 1981;240:H676-9.
17. Boltwood CM Jr, Appleyard RF, Glantz SA. Left ventricular volume measurement by conductance catheter in intact dogs: Parallel conductance volume depends on left ventricular size. Circulation 1989;80:1360-77.
18. Glantz SA, Boltwood CM Jr, Appleyard RF, Applegate RJ, Cheng CP, Little WC. Volume conductance catheter. Circulation1990;81:2028.
19. Slinker BK, Glantz SA. Multiple regression for physiological data analysis; the problem of multicollinearity. Am J Physiol 1985;249:R1-12.
20. Ryan TA Jr, Joiner BL, Ryan BF. MINITAB student handbook. Boston: PWS-Kent Publishing Co., 1985.
21. Dixon WJ (ed). BMDP Statistical Software Manual, Vol. 1. Berkeley: University of California Press,1988;147-9.
22. Hsia TC. System identification. Lexington, MA: DC Heath & Co.,1977;77-81.
23. Gunst RF, Mason RL. Regression analysis and its application; a data-oriented approach. New York: Dekker,1980; 234-6.
24. Glantz SA, Slinker BK. Primer of applied regression and analysis of variance. New York: McGraw-Hill,1990;239-69.
25. Slinker BK, Campbell KB, Ringo JA, Klavano PA, Robinette JD, Alexander JE. Mechanical determinants of transient changes in stroke volume. Am J Physiol 1984;246:H435-47.
26. Jewell BR, Rovell JM. Influence of previous mechanical events on the contractility of isolated cat papillary muscle. J Physiol (Lond) 1973;235:715-40.
27. Kaufman RL, Lab MJ, Hennekes R, Krause H. Feedback interaction of mechanical and electrical events in isolated mammalian ventricular myocardium (cat papillary muscle). Pflügers Arch 1971;324:100-23.
28. Wohlfart B. Analysis of mechanical altemans in rabbit papillary muscle. Acta Physiol Scand 1982;115:405-14.
29. Parmley WW, Brutsaert DL, Sonnenblick EH. Effects of altered loading on contractile events in isolated cat papillary muscle. Circ Res 1969;24:521-32.
30. Suga H, Sagawa K. Transient force responses in blood-perfused papillary muscle after step changes in load. Am J Physiol 1978;235:H267-75.